Drug Topics
JULY 28, 2023
Zavegepant (Zavzpret) is the first and only calcitonin gene-related peptide (CGRP) receptor antagonist nasal spray approved by the FDA for acute migraine treatment in adults.
PharmaVoice
JULY 24, 2023
Amid a wave of neuro R&D, scientists are taking an Alzheimer’s-like approach to developing the first disease-modifying treatments for Parkinson’s.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
JULY 28, 2023
Author of the book The Journey’s End discusses how extending life at all costs takes away time that patients could be spending with their families during the last moments of their life.
STAT
JULY 28, 2023
Canan Dagdeviren has dedicated her career to creating tools that can capture data from every nook and cranny of the human body. An electrode that reads brain signals in Parkinson’s patients. A tattoo-like patch to detect skin cancer. And now, a bra containing a flexible ultrasound that could one day be used to more comfortably screen for breast cancer.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
JULY 26, 2023
The Equitable Community Access to Pharmacy Services legislation was introduced earlier this year in the House of Representatives.
PharmaVoice
JULY 28, 2023
Head honchos at the biggest pharma companies reporting second-quarter earnings dig into the topics du jour.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
JULY 28, 2023
A new Netflix TV show about the origins and consequences of the opioid epidemic is coming to the small screen. The show, “Painkiller,” is a fictional story based on real events that transpired around the Sackler family, Purdue Pharma, and the marketing and distribution of their drug, OxyContin. It adds to the growing list of television shows and movies around America’s opioid crisis, including Netflix’s own “The Pharmacist,” Hulu’s “Dopesic
Drug Topics
JULY 25, 2023
Radiation therapy was associated with the largest increase, compared to chemotherapy or endocrine therapies.
PharmaVoice
JULY 26, 2023
In challenging AbbVie for share of a $19 billion drug market, competitors are testing whether high upfront discounts or behind-the-scenes rebates can win them an advantage.
Pharmacy Times
JULY 28, 2023
The approval of RiVive naloxone hydrochloride nasal spray for nonprescription use provides another tool to help quickly reverse the effects of opioid overdose.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
European Pharmaceutical Review
JULY 28, 2023
A research paper has reported a practical framework suitable for a systematic step-by-step quality by design (QbD) approach for the pharmaceutical development of bilayer tablets. According to the authors, bilayer tablets have been considered one of the best options for the development of fixed-dose combination (FDC) formulations. By delivering active substances, they can avoid incompatibilities in solubility, stability, and therapeutic efficacy in a single dosage form.
Drug Topics
JULY 28, 2023
A recent study determined over 12,000 screenings would need to be done to identify 1 case of melanoma in racial and ethnic minority populations.
PharmaVoice
JULY 26, 2023
Perrigo received the first FDA approval for an OTC birth control pill. Now, its global VP of women’s health says the company is working on the next challenge — affordability.
Pharmacy Times
JULY 28, 2023
Pharmacists play a key role in migraine management, therefore, awareness of menstrual migraine-specific prophylaxis is important.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
pharmaphorum
JULY 28, 2023
1000Farmacie Secures $25 Million in Series A Funding Nicole.
Drug Topics
JULY 28, 2023
Demetre Daskalakis, MD, MPH, urged those in the LGBTQ+ community to get fully vaccinated against the disease.
PharmaVoice
JULY 26, 2023
Over 100 biotech companies so far this year have cut staff due to persistent funding challenges.
Pharmacy Times
JULY 27, 2023
Further analysis shows that 300 mg lenacapvir tablets plus an optimized background regimen can effectively reconcile a missed dose of lenacapavir injection in patients with HIV.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmaceutical Technology
JULY 28, 2023
NS Pharma’s candidate would be the first to target Duchenne Muscular Dystrophy (DMD) patients amenable to exon 44 skipping therapy.
Drug Topics
JULY 28, 2023
According to the CDC, HPV is the most commonly sexually transmitted infection in the US, with a prevalence of 45.2% of men and 39.9% of women aged 18-59 in 2013-2014.
PharmaVoice
JULY 25, 2023
Loïc Vincent, chief scientific officer at Affini-T, explains the company’s T cell approach and latest moves toward the clinic.
Pharmacy Times
JULY 27, 2023
Consuming a vegetarian diet lowered LDL-C, HbA1C, and body weight when compared to a usual diet, but did not significantly affect systolic blood pressure levels.
Fierce Healthcare
JULY 28, 2023
Lobbying groups representing different camps of the healthcare industry have come together to urge the Centers for Medicare & Medicaid Service (CMS) to reconsider “conflicting regulatory propos | The American Hospital Association, American Medical Association and Blue Cross Blue Shield Association penned a joint letter highlighting "conflicting" prior authorization electronic standards and workflows they say will bring industry confusion and unnecessary burden.
Drug Topics
JULY 27, 2023
A new study found that 25%-46% of esophageal adenocarcinomas in patients with newly diagnosed Barrett’s esophagus were categorized as post-endoscopy esophageal adenocarcinoma.
PharmaVoice
JULY 25, 2023
Merck has invested for more than a decade in reducing maternal death rates in the U.S. and globally. Now for the next chapter.
Pharmacy Times
JULY 27, 2023
The risk could double if the conditions are met, with deaths more common in women and those aged 80 and older.
Fierce Healthcare
JULY 28, 2023
The time is now 90 seconds to midnight, according to the Doomsday Clock, which scientists use to estimate how close humanity might be to blowing itself up with nuclear weapons. | The world hasn't been this close to nuclear war since the Cold War, say experts. Editors of prestigious medical journals sound a call to disarm.
Drug Topics
JULY 27, 2023
The National Rosacea Society found that a lack of health insurance or the high cost of a copay caused 52% of respondents to avoid obtaining medical care for their rosacea.
PharmaVoice
JULY 24, 2023
Commercial teams need to accept the reality of declining pharmacy reimbursement as an important variable in their go-to-market equation.
Pharmacy Times
JULY 27, 2023
A study shows the first 2 years of life are a vital time to establish healthy sleep routines in infant children.
pharmaphorum
JULY 28, 2023
After cutbacks, Biogen adds new drug with $7.3bn Reata buy Phil.
Drug Topics
JULY 27, 2023
A minimum dose of 3.4 to 3.6 minutes of vigorous intermittent lifestyle physical activity per day was associated with a 17% to 18% reduction in total incident cancer risk.
The Checkup by Singlecare
JULY 28, 2023
When your healthcare provider places the blood pressure cuff around your arm, you likely hope you won’t have high blood pressure. Hypertension is a common medical condition, but did you know there’s also a possibility your blood pressure could be too low? Turns out, a lot can be revealed as that cuff tightens around your biceps. Blood pressure is a measure of heart and vascular health, specifically the force of blood force flowing through blood vessels.
Expert insights. Personalized for you.
469 
Let's personalize your content